☆ 4.5 Article

3-Arylidene-2-oxindoles as GSK3β inhibitors and anti-thrombotic agents

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2023)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

3-Arylidene-2-oxindoles as Potent NRH:Quinone Oxidoreductase 2 Inhibitors

Natalia A. Lozinskaya et al.

Summary: The enzyme NRH:quinone oxidoreductase 2 (NQO2) is involved in the progression of various diseases and is known to be increased in some cancer cell lines. This study examined the activity of 3-arylidene-2-oxindoles, commonly used in the design of new anticancer drugs, as NRH:quinone oxidoreductase inhibitors. The most active compounds showed significant inhibition of NQO2, but there was no correlation between their inhibition activity and cytotoxic effect on cancer cells.

MOLECULES (2023)

Add to Collection

Article Chemistry, Medicinal

Towards multi-target antidiabetic agents: In vitro and in vivo evaluation of 3,5-disubstituted indolin-2-one derivatives as novel α-glucosidase inhibitors

Vladlen G. Klochkov et al.

Summary: This study presents potent alpha-glucosidase inhibitors that can prevent postprandial hyperglycemia and also demonstrate GSK3beta inhibitory activity. The most active compound identified showed promising results in inhibiting yeast alpha-glucosidase and preventing hyperglycemia in rats. Two lead inhibitors also exhibited submicromolar potency as GSK3P inhibitors, providing a foundation for the development of dual GSK3 beta/alpha-glucosidase inhibitors for the treatment of type 2 diabetes.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2022)

Add to Collection

Article Chemistry, Medicinal

Discovery of Nitro-azolo[1,5-a]pyrimidines with Anti-Inflammatory and Protective Activity against LPS-Induced Acute Lung Injury

Alexander Spasov et al.

Summary: Researchers have identified a promising pharmacological approach for the treatment of acute lung injury, which involves the inhibition of excessive inflammation and cytokine release. A compound named 9g was found to effectively suppress inflammation without causing cytotoxicity and showed potential in ameliorating symptoms of acute lung injury in a mouse model.

PHARMACEUTICALS (2022)

Add to Collection

Article Pharmacology & Pharmacy

SYNTHESIS, ANTIAGGREGATION AND ANTITROMBOTIC ACTIVITIES OF NEW DERIVATIVES OF HYDROXYBENZOIC ACIDS WITH TAURIC FRAGMENT

A. K. Brel et al.

Summary: A high prevalence of thrombotic disorders and safety concerns with antithrombotic therapy are urgent issues in modern healthcare. Acetylsalicylic acid is the main method for preventing thrombosis. New antiplatelet agents, including modifications of the acetylsalicylic acid molecule, are being developed. The synthesized compounds show better solubility than aspirin and exhibit significant antiplatelet and antithrombotic activities, with particular effectiveness in models of arterial thrombosis in older or diabetic animals.

PHARMACY & PHARMACOLOGY-FARMATSIYA I FARMAKOLOGIYA (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Opposing Roles of GSK3α and GSK3β Phosphorylation in Platelet Function and Thrombosis

Samantha F. Moore et al.

Summary: Phosphorylation-resistant GSK3 alpha/beta expression affects platelet activation, with differential roles of GSK3 alpha and GSK3 beta phosphorylation in regulating platelet function.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Interplay between inflammation and thrombosis in cardiovascular pathology

Konstantin Stark et al.

Summary: Thrombosis is a major health challenge globally, with inflammation playing a crucial role in driving thrombotic diseases. Anti-inflammatory strategies show promise in targeting cardiovascular pathologies and addressing therapeutic gaps.

NATURE REVIEWS CARDIOLOGY (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications

James D. McFadyen et al.

CIRCULATION RESEARCH (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Synthesis and biological evaluation of 3-substituted 2-oxindole derivatives as new glycogen synthase kinase 3β inhibitors

Natalia A. Lozinskaya et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2019)

Add to Collection

Review Cardiac & Cardiovascular Systems

Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism

Michela Giustozzi et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2019)

Add to Collection

Review Respiratory System

Cancer-associated thrombosis: the when, how and why

Caio J. Fernandes et al.

EUROPEAN RESPIRATORY REVIEW (2019)

Add to Collection

Article Chemistry, Medicinal

Mathematical and Structural Characterization of Strong Nonadditive Structure-Activity Relationship Caused by Protein Conformational Changes

Laurent Gomez et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Add to Collection

Article Biochemistry & Molecular Biology

The Myosin II Inhibitor, Blebbistatin, Ameliorates FeCl3-induced Arterial Thrombosis via the GSK3β-NF-κB Pathway

Yuanyuan Zhang et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)

Add to Collection

Article Oncology

An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia

David A. Rizzieri et al.

LEUKEMIA & LYMPHOMA (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Structure-based design of benzo[e]isoindole-1,3-dione derivatives as selective GSK-3β inhibitors to activate Wnt/β-catenin pathway

Hong Yue et al.

BIOORGANIC CHEMISTRY (2015)

Add to Collection

Article Oncology

A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin

Jhanelle E. Gray et al.

INVESTIGATIONAL NEW DRUGS (2015)

Add to Collection

Article Neurosciences

A Phase II Trial of Tideglusib in Alzheimer's Disease

Simon Lovestone et al.

JOURNAL OF ALZHEIMERS DISEASE (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Dual Regulation of Glycogen Synthase Kinase 3 (GSK3)α/β by Protein Kinase C (PKC)α and Akt Promotes Thrombin-mediated Integrin αIIbβ3 Activation and Granule Secretion in Platelets

Samantha F. Moore et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2013)

Add to Collection

Article Immunology

Antiplatelet Activity of Valproic Acid Contributes to Decreased Soluble CD40 Ligand Production in HIV Type 1-Infected Individuals

Donna C. Davidson et al.

JOURNAL OF IMMUNOLOGY (2011)

Add to Collection

Article Hematology

GSK3 beta is a negative regulator of platelet function and thrombosis

Dongjun Li et al.

BLOOD (2008)

Add to Collection

Article Chemistry, Medicinal

Selectivity criterion for pyrazolo[3,4-b]pyrid[az]ine derivatives as GSK-3 inhibitors:: CoMFA and molecular docking studies

Dhilon S. Patel et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2008)

Add to Collection

Article Chemistry, Medicinal

Assessment of Additive/Nonadditive Effects in Structure-Activity Relationships: Implications for Iterative Drug Design

Yogendra Patel et al.

JOURNAL OF MEDICINAL CHEMISTRY (2008)

Add to Collection

Article Biochemistry & Molecular Biology

Regulation of glycogen synthase kinase 3 in human platelets: a possible role in platelet function?

FA Barry et al.

FEBS LETTERS (2003)

Add to Collection

Article Biochemistry & Molecular Biology

Indirubins inhibit glycogen synthase kinase-3β and CDK5/P25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease -: A property common to most cycline-dependent kinase inhibitors?

S Leclerc et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.